The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type i interferon

Cell Host and Microbe

Volumn 16, Issue 3, 2014, Pages 314-327

  Laurent Rolle, Maudry ^a   Morrison, Juliet ^a   Rajsbaum, Ricardo ^a   Macleod, Jesica M Levingston ^a   Pisanelli, Giuseppe ^a,b   Pham, Alissa ^a   Ayllon, Juan ^a   Miorin, Lisa ^a   Martínez Romero, Carles ^a   Tenoever, Benjamin R ^a   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LIGASE; LYSINE; NONSTRUCTURAL PROTEIN 5; STAT1 PROTEIN; STAT2 PROTEIN; BETA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; NS5 PROTEIN, FLAVIVIRUS; PROTEIN BINDING; STAT1 PROTEIN, HUMAN; TRIM23 PROTEIN, HUMAN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION; YELLOW FEVER FLAVIVIRUS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHOSPHORYLATION; PROTEIN MOTIF; VIROLOGY; YELLOW FEVER; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; GTP-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; VIRAL NONSTRUCTURAL PROTEINS; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84907700872     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.07.015     Document Type: Article

References (54)

1. S. Aguirre, A.M. Maestre, S. Pagni, J.R. Patel, T. Savage, D. Gutman, K. Maringer, D. Bernal-Rubio, R.S. Shabman, and V. Simon DENV inhibits type I IFN production in infected cells by cleaving human STING PLoS Pathog. 8 2012 e1002934
2. N. Ank, H. West, C. Bartholdy, K. Eriksson, A.R. Thomsen, and S.R. Paludan Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo J. Virol. 80 2006 4501 4509
3. K. Arimoto, K. Funami, Y. Saeki, K. Tanaka, K. Okawa, O. Takeuchi, S. Akira, Y. Murakami, and K. Shimotohno Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense Proc. Natl. Acad. Sci. USA 107 2010 15856 15861
4. J. Ashour, M. Laurent-Rolle, P.Y. Shi, and A. García-Sastre NS5 of dengue virus mediates STAT2 binding and degradation J. Virol. 83 2009 5408 5418
5. J. Ashour, J. Morrison, M. Laurent-Rolle, A. Belicha-Villanueva, C.R. Plumlee, D. Bernal-Rubio, K.L. Williams, E. Harris, A. Fernandez-Sesma, C. Schindler, and A. García-Sastre Mouse STAT2 restricts early dengue virus replication Cell Host Microbe 8 2010 410 421
6. A.D. Barrett, T.P. Monath, V. Barban, M. Niedrig, and D.E. Teuwen 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005 Vaccine 25 2007 2758 2765
7. S.M. Best, K.L. Morris, J.G. Shannon, S.J. Robertson, D.N. Mitzel, G.S. Park, E. Boer, J.B. Wolfinbarger, and M.E. Bloom Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist J. Virol. 79 2005 12828 12839
8. C. Biscayart, M.E. Carrega, S. Sagradini, A. Gentile, D. Stecher, T. Orduna, S. Bentancourt, S.G. Jiménez, L.P. Flynn, and G.P. Arce Yellow fever vaccine-associated adverse events following extensive immunization in Argentina Vaccine 32 2014 1266 1272
9. P.J. Bredenbeek, E.A. Kooi, B. Lindenbach, N. Huijkman, C.M. Rice, and W.J. Spaan A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication J. Gen. Virol. 84 2003 1261 1268
10. J.G. Breugelmans, R.F. Lewis, E. Agbenu, O. Veit, D. Jackson, C. Domingo, M. Böthe, W. Perea, M. Niedrig, B.D. Gessner, S. Yactayo YF AEFI group Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010 Vaccine 31 2013 1819 1829
11. A.J. Brooks, M. Johansson, A.V. John, Y. Xu, D.A. Jans, and S.G. Vasudevan The interdomain region of dengue NS5 protein that binds to the viral helicase NS3 contains independently functional importin beta 1 and importin alpha/beta-recognized nuclear localization signals J. Biol. Chem. 277 2002 36399 36407
12. T.J. Chambers, C.S. Hahn, R. Galler, and C.M. Rice Flavivirus genome organization, expression, and replication Annu. Rev. Microbiol. 44 1990 649 688
13. T.J. Chambers, D.W. McCourt, and C.M. Rice Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera Virology 177 1990 159 174
14. M. Chen, and D. Gerlier Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy Viral Immunol. 19 2006 349 362
15. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc. Natl. Acad. Sci. USA 95 1998 15623 15628
16. M.S. Diamond Mechanisms of evasion of the type I interferon antiviral response by flaviviruses J Interferon Cytokine Res 29 2009 521 530
17. M.S. Diamond, T.G. Roberts, D. Edgil, B. Lu, J. Ernst, and E. Harris Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons J. Virol. 74 2000 4957 4966
18. C.N. dos Santos, P.R. Post, R. Carvalho, I.I. Ferreira, C.M. Rice, and R. Galler Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213 Virus Res. 35 1995 35 41
19. J. El Bougrini, L. Dianoux, and M.K. Chelbi-Alix PML positively regulates interferon gamma signaling Biochimie 93 2011 389 398
20. N. Frias-Staheli, N.V. Giannakopoulos, M. Kikkert, S.L. Taylor, A. Bridgen, J. Paragas, J.A. Richt, R.R. Rowland, C.S. Schmaljohn, and D.J. Lenschow Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses Cell Host Microbe 2 2007 404 416
21. M.U. Gack, Y.C. Shin, C.H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J.U. Jung TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity Nature 446 2007 916 920
22. J.L. Hadler, D. Patel, K. Bradley, J.M. Hughes, C. Blackmore, P. Etkind, L. Kan, J. Getchell, J. Blumenstock, J. Engel Centers for Disease Control and Prevention (CDC) National capacity for surveillance, prevention, and control of West Nile virus and other arbovirus infections - United States, 2004 and 2012 MMWR Morb. Mortal. Wkly. Rep. 63 2014 281 284
23. C.S. Hahn, J.M. Dalrymple, J.H. Strauss, and C.M. Rice Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it Proc. Natl. Acad. Sci. USA 84 1987 2019 2023
24. J. Hemelaar, A. Borodovsky, B.M. Kessler, D. Reverter, J. Cook, N. Kolli, T. Gan-Erdene, K.D. Wilkinson, G. Gill, and C.D. Lima Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins Mol. Cell. Biol. 24 2004 84 95
25. C.M. Horvath Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein Eur. J. Biochem. 271 2004 4621 4628
26. C.M. Horvath, G.R. Stark, I.M. Kerr, and J.E. Darnell Jr. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex Mol. Cell. Biol. 16 1996 6957 6964
27. T. Improta, C. Schindler, C.M. Horvath, I.M. Kerr, G.R. Stark, and J.E. Darnell Jr. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein Proc. Natl. Acad. Sci. USA 91 1994 4776 4780
28. M. Issur, B.J. Geiss, I. Bougie, F. Picard-Jean, S. Despins, J. Mayette, S.E. Hobdey, and M. Bisaillon The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure RNA 15 2009 2340 2350
29. M. Jones, A. Davidson, L. Hibbert, P. Gruenwald, J. Schlaak, S. Ball, G.R. Foster, and M. Jacobs Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression J. Virol. 79 2005 5414 5420
30. M. Laurent-Rolle, E.F. Boer, K.J. Lubick, J.B. Wolfinbarger, A.B. Carmody, B. Rockx, W. Liu, J. Ashour, W.L. Shupert, and M.R. Holbrook The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling J. Virol. 84 2010 3503 3515
31. S. Leung, S.A. Qureshi, I.M. Kerr, J.E. Darnell Jr., and G.R. Stark Role of STAT2 in the alpha interferon signaling pathway Mol. Cell. Biol. 15 1995 1312 1317
32. R.J. Lin, B.L. Chang, H.P. Yu, C.L. Liao, and Y.L. Lin Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism J. Virol. 80 2006 5908 5918
33. J. Lin, R. Buettner, Y.C. Yuan, R. Yip, D. Horne, R. Jove, and N. Vaidehi Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3 J. Mol. Graph. Model. 28 2009 347 356
34. B.D. Lindenbach, and C.M. Rice Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function J. Virol. 73 1999 4611 4621
35. B.D. Lindenbach, and C.M. Rice Molecular biology of flaviviruses Adv. Virus Res. 59 2003 23 61
36. M. Mazzon, M. Jones, A. Davidson, B. Chain, and M. Jacobs Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation J. Infect. Dis. 200 2009 1261 1270
37. R. McKendry, J. John, D. Flavell, M. Müller, I.M. Kerr, and G.R. Stark High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons Proc. Natl. Acad. Sci. USA 88 1991 11455 11459
38. F.W. McNab, R. Rajsbaum, J.P. Stoye, and A. O'Garra Tripartite-motif proteins and innate immune regulation Curr. Opin. Immunol. 23 2011 46 56
39. T.P. Monath, M.S. Cetron, K. McCarthy, R. Nichols, W.T. Archambault, L. Weld, and P. Bedford Yellow fever 17D vaccine safety and immunogenicity in the elderly Hum. Vaccin. 1 2005 207 214
40. Y. Morishima, A.M. Wang, Z. Yu, W.B. Pratt, Y. Osawa, and A.P. Lieberman CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins Hum. Mol. Genet. 17 2008 3942 3952
41. J. Morrison, M. Laurent-Rolle, A.M. Maestre, R. Rajsbaum, G. Pisanelli, V. Simon, L.C. Mulder, A. Fernandez-Sesma, and A. García-Sastre Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling PLoS Pathog. 9 2013 e1003265
42. M. Müller, C. Laxton, J. Briscoe, C. Schindler, T. Improta, J.E. Darnell Jr., G.R. Stark, and I.M. Kerr Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways EMBO J. 12 1993 4221 4228
43. M.S. Park, M.L. Shaw, J. Muñoz-Jordan, J.F. Cros, T. Nakaya, N. Bouvier, P. Palese, A. García-Sastre, and C.F. Basler Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins J. Virol. 77 2003 1501 1511
44. S.A. Qureshi, S. Leung, I.M. Kerr, G.R. Stark, and J.E. Darnell Jr. Function of Stat2 protein in transcriptional activation by alpha interferon Mol. Cell. Biol. 16 1996 288 293
45. R. Rajsbaum, G.A. Versteeg, S. Schmid, A.M. Maestre, A. Belicha-Villanueva, C. Martínez-Romero, J.R. Patel, J. Morrison, G. Pisanelli, and L. Miorin Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response Immunity 40 2014 880 895
46. C.M. Rice, E.M. Lenches, S.R. Eddy, S.J. Shin, R.L. Sheets, and J.H. Strauss Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution Science 229 1985 726 733
47. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, P. Bieniasz, and C.M. Rice A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
48. R.T. Taylor, K.J. Lubick, S.J. Robertson, J.P. Broughton, M.E. Bloom, W.A. Bresnahan, and S.M. Best TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase Cell Host Microbe 10 2011 185 196
49. M.K. Tse, S.K. Hui, Y. Yang, S.T. Yin, H.Y. Hu, B. Zou, B.C. Wong, and K.H. Sze Structural analysis of the UBA domain of X-linked inhibitor of apoptosis protein reveals different surfaces for ubiquitin-binding and self-association PLoS ONE 6 2011 e28511
50. P.D. Uchil, A. Hinz, S. Siegel, A. Coenen-Stass, T. Pertel, J. Luban, and W. Mothes TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity J. Virol. 87 2013 257 272
51. G.A. Versteeg, R. Rajsbaum, M.T. Sánchez-Aparicio, A.M. Maestre, J. Valdiviezo, M. Shi, K.S. Inn, A. Fernandez-Sesma, J. Jung, and A. García-Sastre The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors Immunity 38 2013 384 398
52. K. Werme, M. Wigerius, and M. Johansson Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling Cell. Microbiol. 10 2008 696 712
53. Y. Zhou, D. Ray, Y. Zhao, H. Dong, S. Ren, Z. Li, Y. Guo, K.A. Bernard, P.Y. Shi, and H. Li Structure and function of flavivirus NS5 methyltransferase J. Virol. 81 2007 3891 3903
54. Z. Zhou, O.J. Hamming, N. Ank, S.R. Paludan, A.L. Nielsen, and R. Hartmann Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases J. Virol. 81 2007 7749 7758